Physician profile
Jamison Wyatt
NPI 1568642361
$26,506.53
in general payments reported to CMS, 2019-2025
44 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,330 · 2020: $1,090 · 2021: $914 · 2022: $1,928 · 2023: $1,780 · 2024: $4,888 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $13K · Food and Beverage: $4,921 · Travel and Lodging: $2,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,666.67 |
| Food and Beverage | $4,920.99 |
| Travel and Lodging | $2,657.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,666.67 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $4,633.54 | 2019-2025 | Triclip, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,997.56 | 2019-2025 | Latitude Communicator Power Supply, Wolverine Coronary Cutting Balloon, Watchman Access System |
| Medtronic, INC. | $1,165.16 | 2021-2025 | Corevalve Evolut R, Venaseal, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $663.50 | 2019-2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $626.21 | 2022-2025 | Artis Q Floor, Artis Q Ceiling, Artis Pheno |
| Medtronic Vascular, INC. | $463.32 | 2019-2020 | |
| Abiomed | $455.62 | 2019-2025 | |
| Biosense Webster, INC. | $395.93 | 2019-2023 | Carto 3 |
| Teleflex LLC | $316.20 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.68 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $274.18 | 2019-2025 | |
| Philips North America LLC | $272.71 | 2021-2024 | (5153) Azurion 5 M20 Gc, (P84) Igt Devices Systems |
| Cardiovascular Systems INC. | $230.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $190.67 | 2019-2023 | Brilinta |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $174.89 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Biotronik INC. | $164.12 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $158.63 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $136.10 | 2020-2023 | Camzyos |
| Reflow Medical INC | $127.78 | 2024-2025 | |
| Acist Medical Systems, INC. | $116.39 | 2021-2024 | |
| Edwards Lifesciences Corporation | $111.82 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $96.01 | 2021-2024 | Repatha |
| Pfizer INC. | $90.42 | 2019-2022 | |
| Inari Medical, INC. | $82.67 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $77.33 | 2022-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.05 | 2019-2024 | Jardiance |
| Shockwave Medical, INC | $58.63 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $50.34 | 2019-2020 | |
| Atricure, INC. | $43.03 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cvrx, INC. | $38.52 | 2022-2023 | Barostim Neo System |
| Amarin Pharma, INC. | $38.42 | 2019 | |
| Surmodics, INC. | $31.33 | 2022 | |
| Chiesi USA, INC. | $29.72 | 2021 | |
| Inspire Medical Systems, INC. | $23.36 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $21.82 | 2025 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $21.71 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.33 | 2019 | |
| Impulse Dynamics (USA) INC. | $17.95 | 2022 | |
| Scpharmaceuticals INC. | $16.17 | 2025 | |
| Bard Peripheral Vascular, INC. | $15.95 | 2025 | True Flow |
| Davol INC. | $15.10 | 2022 | |
| Cardinal Health 200 LLC | $13.46 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamison Wyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.